Wall Street ended lower on more declines in technology stocks, but the market pared its losses in the afternoon ...

Viking's key drug demonstrated excellent body weight reduction data in a phase 2 trial, but its safety and tolerability data ...

Nvidia, Palantir and other superstar stocks that had surged in the mania surrounding artificial-intelligence technology are ...

Still, it is highly important to note that Renaissance's positioning in NVIDIA tends to change dramatically from quarter to quarter. This strongly suggests that the firm is trading the stock rather ...